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Purpose: To investigate the pathological changes of the meibomian gland (MG) and ocular surface in
Apolipoprotein E knockout (ApoE−/−) mice and to investigate the association of meibomian gland dysfunction
(MGD) with hyperlipidemia.
Methods: Total plasma cholesterol was measured in different ages of ApoE−/− and wild type (WT) mice, whilst
the ocular surfaces were observed by slit-lamp biomicroscopy. MG sections were subjected to H&E staining, Oil
Red O staining, TUNEL assay and immunostaining. Quantitate RT-PCR and Western blot analyses were per-
formed to detect the relative gene expression in MGs. The 5-month-old ApoE−/− mice were administered with
rosiglitazone or GW9662 + rosiglitazone via oral gavage for 2 months to determine their effect on MG pa-
thological change.
Results: We found eyelid abnormality, MG dropout, abnormal MG acinar morphology, dilated MG duct and
plugging of the MG orifice in ApoE−/−mice. MG acini in ApoE−/−mice showed exaggerated lipid accumulation.
Abnormal keratinization increased in MG duct, accompanied with decreased proliferation and increased
apoptosis in ApoE−/− mice. Inflammatory cells infiltrated into the surrounding microenvironment of MG acini,
and the NF-κB signaling pathway was activated in MG acinar cells. Oxidative stress was evident in MG acinar
cells of ApoE−/− mice. Further investigation showed downregulation of PPAR-γ in MG acinar cells of ApoE−/−
mice. PPAR-γ agonist rosiglitazone treatment reduced the morbidity of eyelid, as well as corneal pathological
changes and MG inflammation in ApoE−/− mice.
Conclusion: MGD and hyperlipidemia are closely associated in ApoE−/− mice, which represent a new model to
study the pathophysiology of MGD related to dyslipidemia.
1. Introduction
Meibomian glands (MGs), a type of modified, holocrine sebaceous
glands of the eyelid margin, are arranged vertically in the upper and
lower tarsal plates [1]. MGs maintain ocular surface homeostasis by
secreting specialized lipids to the tear film, which functions to avert
tear evaporation, smoothen the ocular surface, and form a barrier to
protect the eye from microbial agents and organic matter [2–6]. Mei-
bomian gland dysfunction (MGD) is defined as a chronic, diffuse ab-
normality of the MGs, commonly characterized by terminal duct ob-
struction and/or qualitative/quantitative changes in the glandular
secretion [7]. MGD may result in alteration of the tear film stability,
symptoms of eye irritation, clinically apparent inflammation, and
ocular surface disease [2,8]. MGD is the most common cause of eva-
porative dry eye [9], and results in significant negative effects on life
quality of the dry eye sufferers [10,11].
Apolipoprotein E (ApoE) is a component of plasma lipoproteins and
serves as a ligand for cell-surface lipoprotein receptors such as low
density lipoprotein (LDL)-receptor (LDLR), LDLR related proteins, very
low-density lipoprotein (VLDL), and high-density lipoprotein (HDL)
[12]. It is synthesized in the liver and macrophages, and plays an im-
portant role in mediating cholesterol metabolism in an isoform-de-
pendent manner [13,14]. Apolipoprotein E knockout (ApoE−/−) mice
are characterized by marked increase in total plasma cholesterol levels
of more than 500mg/dL, and develop microvasculature lesions [15].
They also demonstrate decreased clearance of remnant lipoproteins that
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leads to hypercholesterolemia and hypertriglyceridemia [16]. The le-
sions increase with age and progress to atherosclerotic lesion [17].
Thus, ApoE−/− mice are the most widely used murine model to study
the mechanisms of hyperlipidemia and atherosclerosis [18,19].
In recent years, several clinical studies reported that patients with
moderate-to-severe MGD had abnormal serum cholesterol levels
[20,21], and that the severity of the MGD increased with high serum
triglyceride and low-density lipoprotein levels [22]. These findings
suggest that MGD may be related to abnormal lipid metabolism.
However, whether or not the MGD has a direct relationship with dys-
lipidemia remains elusive. In this study, we investigated the patholo-
gical changes of the MG and ocular surface in ApoE−/− mice and il-
lustrate a clear association of MGD with hyperlipidemia.
2. Materials and methods
2.1. Materials
Rabbit anti-Ki67 (ab16667), anti-P63 (ab124762), anti-Cytokeratin
10 (ab76318), anti-TNF-α (ab66579), anti-NADPH oxidase 4 (NOX-4,
ab133303), anti-4 Hydroxynonenal (4-HNE, ab46545), anti-PPAR-γ
(ab45036) antibodies, and mouse anti-3-Nitrotyrosine antibody (3-NT
ab61392) were from Abcam (Cambridge, UK). Rabbit anti-AC-caspase-8
(sc-7890), rat anti-CD45 (sc-52491) antibodies, Rosiglitazone (sc-
202795) and GW9662 (sc-202641) were from Santa Cruz
Biotechnology (Dallas, TX, USA). Rabbit anti-IL-6 (Cat#12912S), anti-
NF-κB p65 (Cat#8242) and anti-phospho-NF-κB p65 (Cat#3033) anti-
bodies were from Cell Signaling Technology (Danvers, MA, USA). Anti-
FABP5 (PA5-47143), Alexa Fluor 594-conjugated IgG (A11058) and
Alexa Fluor 488-conjugated IgG (A11055, A21206) were from
Invitrogen (Eugene, OR, USA). Horseradish peroxidase (HRP)-con-
jugated anti-β-actin antibody (a5316) was from Sigma-Aldrich (St.
Louis, MO, USA). 40,6-diamidino-2-phenylindole (DAPI; H-1200) and
mounting medium (H-5000) were from Vector (Burlingame, CA, USA).
2.2. Animals
Male ApoE−/− mice aged 3, 5, and 7 months and age and sex
matched wild type (WT) mice were used in this study. The ApoE−/−
mice were from Beijing Vital River Laboratory Animal Technology Co.,
Ltd (Beijing, China), and the wild-type C57BL/6 mice were purchased
from Shanghai SLAC Laboratory Animal Center (Shanghai, China). All
studies were performed in accordance with the Association for Research
in Vision and Ophthalmology (ARVO) Statement for the Use of Animals
in Ophthalmic and Vision Research, and with the approval of the
Animal Ethical Committee of Xiamen University. Animals were given
free access to standard rodent chow and water and kept in standard
pathogen-free environment at 25 °C ± 1 °C, relative humidity
60% ± 10%, and alternating 12 h light-dark cycles (from 8:00 a.m. to
8:00 p.m.).
2.3. Animal examination
All the animals were weighed, after which the eyelid margins and
corneas were imaged in a masked fashion under a slit-lamp microscope
(Kanghua Science & Technology Co. Ltd., Chongqing, China) by a single
ophthalmologist. After that, 1 μL of 1% liquid sodium fluorescein
(Jingmingxin Co., Ltd., Tianjin, China) was dropped into the con-
junctival sac, and corneal epithelial fluorescein staining was recorded
90 s later under the slit-lamp microscope with a cobalt blue filter. The
grade of corneal damage was designated based on previously reported
criteria [23]. Corneal neovascularization was also observed and re-
corded. Five mice in each group were sacrificed and the upper and
lower eyelids were excised en bloc, after which the MG structure was
clinically photographed with a stereoscopic zoom microscope (Leica
M165-FC; Germany).
2.4. Plasma cholesterol measurements
Blood samples (five mice per group) were collected from both WT
and ApoE−/−mice by cardiac puncture at the time of sacrifice and
stored at −80 °C. Serum total cholesterol was measured enzymatically
using a commercially available kit (ab65390, Abcam, Cambridge, UK)
in accordance with the manufacturer's instructions.
2.5. Histology
Eyelid tissues were collected from WT and ApoE−/− mice and em-
bedded in optimal cutting temperature (OCT) compound or paraffin,
cut into sagittal sections (5 μm thick, two sections per slide, three slides
per animal, three animals per group), and then stored at −80 °C (frozen
sections) or room temperature (paraffin sections).
Immunohistochemical staining and TUNEL assay were performed on
the paraffin sections, and immunofluorescence staining, Oil Red O,
Hematoxylin and Eosin staining were performed on frozen sections.
2.6. Oil Red O staining
Frozen eyelid sections were fixed in 4% paraformaldehyde for
10min, washed in PBS for 5min, and stained for 10min in freshly
prepared Oil Red O solution. After rinsing with PBS for 5min, the
sections were counterstained with hematoxylin and mounted in 90%
glycerol.
2.7. TUNEL assay
Cell apoptosis detection was performed using the DeadEnd™
Fluorometric TUNEL System (Promega, G3250). MG sections were re-
hydrated and incubated with Proteinase K Tris/HCL, pH=7.4 (10mM)
for 30min at 37 °C. The MG sections were washed three times with PBS
for 5min each. Then, 50 μL of TUNEL reaction mixture was added and
the sections placed in the dark for 1 h at 37 °C. The specimens were
rinsed three times with PBS for 5min each, counterstained with DAPI,
mounted, and photographed with a microscope (DM2500; Leica
Microsystems, Wetzlar, Germany).
2.8. Immunofluorescence staining
For immunofluorescence staining, sections were fixed in cold
acetone (−20 °C) for 10min followed by washing three times using PBS
for 5min each. Sections were incubated with 0.2% Triton X-100 for
20min and again washed three times each with PBS for 5min. Tissue
sections were then blocked with 2% BSA in PBS for 60min at room
temperature and incubated with Ki67 (1:300), p63 (1:200), Cytokeratin
10 (1:200), FABP5 (1:50), AC-caspase-8 (1:50), IL-6 (1:200), TNF-α
(1:200), NF-κB p65 (1:200), phospho-NF-κB p65 (1:200), PPAR-γ
(1:250) antibodies for 16 h at 4 °C. Negative controls were performed by
incubating a section with PBS without the primary antibody. The slides
were then washed three times with PBS for 10min per wash and in-
cubated with Alexa Fluor 594-conjugated IgG (1:300) or Alexa Fluor
488-conjugated IgG (1:300) for 60min at 37 °C, followed by counter-
staining with DAPI. Sections were then evaluated and imaged with a
microscope (DM2500; Leica Microsystems, Wetzlar, Germany). The
mean intensity of staining in some sections was measured by image
analysis software (NIS Elements version 4.1, Nikon, Melville, NY, USA).
2.9. Immunohistochemical staining
Paraffin sections were rehydrated and blocked with 3% hydrogen
peroxide for 10min, followed by washing three times with PBS for
5min each. Sections were subsequently treated with 0.2% Triton X-100
for 20min. After washing three times each with PBS for 5min, they
were incubated with 2% BSA for 60min, followed by incubation with
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CD45 (1:150), NOX-4 (1:250), 3-NT (1:200), and 4-HNE (1:200) anti-
bodies at 4 °C for 16 h. The next day, after rinsing three times with PBS
for 10min each, the sections were further incubated with biotinylated
anti-rabbit IgG (1:50), anti-rat IgG (1:50) or anti-mouse IgG (1:50) for
60min, followed by Vectastain Elite ABC reagent for 30min. The re-
action product was then developed with diaminobenzidine (DAB) for
1min, mounted with mounting medium, and examined under a light
microscope (Eclipse 50i; Nikon, Tokyo, Japan). Positively stained cells
were counted in the MGs using NIS Elements image analysis software
(NIS Elements version 4.1; Nikon, Melville, NY, USA).
2.10. RNA extraction and qRT-PCR
MGs were isolated under a dissecting microscope by the removal of
skin, subcutaneous tissue, muscle, and palpebral conjunctiva. RNA
sample parameters and concentrations were detected by a Du 800
Nucleic Acid/protein Analyzer (Beckman coulter, US). Five samples
were used in each group, and one sample consisted of pooled MGs of
Fig. 1. Systemic characteristics of ApoE−/− mice. Body weight increased in ApoE−/− mice compared with WT mice (A). Total cholesterol concentrations in the
serum (B). Data are shown as mean ± SD. **p < 0.01, ***p < 0.001.
Fig. 2. ApoE−/− mice exhibits clinical evidence of MGD. Representative slit-lamp images showing the ocular surface of WT mice (A) and hypertrophic eyelid
margins (arrow heads) and corneal neovascularization (7 months, asterisk) in ApoE−/− mice (B). The fluorescein staining score (C) and corneal neovascularization
incidence rate (D) increased in ApoE−/− mice. MG dropout (arrow heads) and morphological changes are seen in ApoE−/− mice in both upper and lower MGs (E).
Data are shown as mean ± SD. ***p < 0.001.
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both eyes of the same mice. The equal amount of RNA was reverse
transcribed to cDNA using a reverse transcription kit (RR047A; TaKaRa,
Shiga, Japan). Quantitative Real-Time PCR (qRT-PCR) was performed
with a StepOneTM Real-Time PCR detection system (Applied
Biosystems, Alameda, CA, USA) using a SYBR Premix Ex TaqKit
(RR420A; TaKaRa, Shiga, Japan), and the specific primer sequences are
available upon request. The thermal profile used was as follows: 95 °C
for 10min, followed by denaturation at 95 °C for 10 s and annealing and
extension at 60 °C for 30 s for 40 cycles. The results of qRT-PCR were
analyzed by the comparative CT method and normalized with β-actin as
an endogenous reference, and calibrated against the normal control
group.
2.11. Western blot analysis
Isolated MGs were extracted in a cold lysis buffer composed of
protease and phosphatase inhibitor. Protein concentration was mea-
sured by BAC protein assay kit (cat#23225; ThermoFisher Scientific,
MA, USA). Five samples were used in each group, and each sample
consisted of pooled MGs of both eyes of the same mice. Equal amounts
of protein extracts (20 μg) were subjected to electrophoresis on 10%
Tricine gels and then electronically transferred to PVDF membranes.
After blocking in 5% BSA for 1 h, the membranes were incubated
overnight at 4 °C with primary antibodies for NF-κB p65 (1:1000),
phospho-NF-κB p65 (1:1000), NOX-4 (1:1000), 3-NT (1:1000), 4-HNE
(1:1000), PPAR-γ (1:1000) and secondary antibodies (HRP-conjugated
goat anti-mouse IgG and HRP-conjugated goat anti-rabbit IgG) were
used. HRP-conjugated mouse anti–β-actin was used for protein quan-
tification. The results were detected by enhanced chemiluminescence
reagent (ECL-500; ECL, Lulong Inc, Xiamen, China) and recorded by the
transilluminator (ChemiDoc XRS System; Bio-Rad, Philadelphia, PA,
USA).
2.12. Statistical analysis
Data were processed using GraphPad Prism 6.0 software (GraphPad
Software Inc, San Diego, CA, USA). Statistical analysis was performed
using the Mann-Whitney test to compare the differences in body
weight, relative mRNA rate, cholesterol concentration, corneal fluor-
escein staining scores, Ki67, P63 and CD45 positive cell counting, in-
tensity of AC-caspase-8 immunofluorescent staining, apoptotic cell
counting. A one-way ANOVA was conducted to analyze differences in
corneal fluorescein staining scores and CD45 positive cell counting in
drug treatment experiments. A value of p < 0.05 was considered sta-
tistically significant.
3. Results
3.1. Eyelid and ocular surface manifestations of ApoE−/− mice
Mice were followed up for 7 months during which time the body
mass of ApoE−/− mice had become significantly higher than that of WT
mice from 3 to 7 months (Fig. 1A). There was also a significant increase
of total cholesterol in the serum of ApoE−/− mice compared to the age-
matched WT mice (Fig. 1B), similar to previous reports [24], suggesting
that ApoE−/− mice are indeed an appropriate model of hyperlipidemia.
Slit lamp images showed no obvious changes in either the eyelids or
the corneas of WT mice from 3 months to 7 months (Fig. 2A). However,
there was a notable amount of punctate corneal staining in 5-month-old
ApoE−/− mice, which was accompanied by corneal neovascularization
Fig. 3. ApoE−/− mice exhibit histological evi-
dence of MGD. Representative H&E staining of
eyelids from 7-month-old WT and ApoE−/− mice.
Red arrow heads indicating the obstructed MG or-
ifice in ApoE−/− mice and unobstructed orifice in
WT mice. Black double-headed arrows showing
MG duct size, indicating that the MG duct in
ApoE−/− mice is significantly dilated.
Representative images of acini showing alterations
in acinar morphology in ApoE−/− mice (A). ORO
staining showing condensed lipid droplets in the
MGs of ApoE−/− mice (B). Scale bars: 50 μm.
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at 7-months (Fig. 2B). The eyelids from ApoE−/− mice were also no-
ticeably hypertrophic compared with the eyelids of WT mice at 5 and 7
months (Fig. 2B). Corneal fluorescein staining increased remarkably in
ApoE−/− mice compared to the WT mice at 5 and 7 months (Fig. 2C).
The incidence of corneal neovascularization also dramatically increased
in 7-month-old ApoE−/− mice (Fig. 2D). MG dropout and plugging of
the MG orifice are key clinical signs of MGD [25,26]. Obvious MG
dropout with disordered acini and ducts in ApoE−/− mice was seen in
both the upper and lower glands in contrast to the dense and organized
MGs in WT mice (Fig. 2E).
H&E staining revealed plugging of the MG orifice, dilation of duct
and heteromorphic acinar morphology (Fig. 3A). In addition, MGs of
ApoE−/− mice showed more condensed ORO staining, especially at the
7 month timepoint (Fig. 3B). Taken together, it is evident that MG
obstruction occurs in ApoE−/− mice, accompanied with MG dropout
and alterations in MG morphology and function.
3.2. Pathological change of MG cells in ApoE−/− mice
We further investigated the proliferation, differentiation and apop-
tosis of MG cells in 5 and 7 month old mice. Ki67 positive cells were
decreased in the acini of MGs from 5 to 7 month old ApoE−/− mice
compared to the age matched WT mice (Fig. 4A and B). This was further
confirmed by Ki67 gene expression (Fig. 3C). The P63 gene, which is
strongly expressed in epithelial cells with high clonogenic and pro-
liferative capacity [27], was apparently decreased in acini in 5 and 7
months old ApoE−/− mice (Fig. 4D and E), as seen by immune-locali-
zation and confirmed by qRT-PCR (Fig. 4F).
Hyper-keratinization is a major pathological change of obstructive
MGD that can result in degenerative gland dilatation and atrophy
[28–30]. K10 is the marker for terminally keratinized epithelium [31].
FABP5 is another keratinization marker, which could induce increased
expression of K10 and involucrin in human keratinocytes [32]. FABP5
is also highly expressed in spinous layers along with upregulation of
K10 in psoriatic skin [33]. Immunofluorescence staining revealed po-
sitive K10 cells in MG acini and duct in 7-month-old ApoE−/− mice, but
only a scant number of positive cells in the MG duct of WT mice
(Fig. 4G). In addition, the 7-month-old ApoE−/− mice showed thick-
ening and hyperkeratosis of the eyelid margin with the K10 positive
cells extended to the palpebral conjunctiva (Fig. 4G, EM). No significant
difference was noticed in 5-month-old ApoE−/− and WT mice (data not
shown). qRT-PCR confirmed upregulated K10 gene expression in MG
tissue of 7-month-old ApoE−/− mice (Fig. 4H). FABP5 was also highly
expressed in 5 and 7 month old ApoE−/− mice (Fig. 4I), as was con-
firmed by qRT-PCR (Fig. 4J). These results indicated that the MGs from
ApoE−/− mice were excessively keratinized.
Quantification of TUNEL positive cells revealed that apoptosis was
promoted in MGs of ApoE−/− mice at both 5 and 7 months (Fig. 4K and
L). The immunofluorescence staining found up-regulated AC-caspase-8
expression in ApoE−/− mice compared with that seen in WT mice
(Figure 4M, N), further pointing to apoptosis in the MG in the mutant
mice.
Fig. 4. Reduced proliferation, hyperkeratinization and increased apoptosis in MG of ApoE−/− mice. Ki67 immunofluorescence staining (A), positive cell
counts (B), and gene expression (C) decreased in ApoE−/− mice. P63 immunofluorescence staining (D), positive cell counts (E), and gene expression (F) also
decreased in ApoE−/− mice. K10 positive cells increased in MG acini (arrow heads), duct (asterisk) and the eyelid margin of 7-month-old ApoE−/− mice (G). K10
gene expression is upregulated in ApoE−/−mice (H). Immunofluorescent staining (I) and mRNA expression (J) of FABP5 showing significant up-regulation in MGs of
ApoE−/−mice compared with those of WT mice. Increased TUNEL assay staining (K) and cell counts (L) reveal increased apoptosis of acinar cells in MGs of ApoE−/−
mice compared with those of WT mice. AC-caspase-8 immunofluorescent staining (M) and intensity analysis (N) indicates higher AC-caspase-8 expression in MGs of
ApoE−/− mice compared with those of WT mice. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 50 μm. Conj, conjunctiva; EM,
eyelid margin.
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3.3. Eyelid tissue inflammation in ApoE−/− mice
CD45 immunohistochemistry staining showed intense periglandular
staining in the MGs of ApoE−/−mice (Fig. 5A), with a higher number of
positive cells than in WT mice (Fig. 5B). IL-6 and TNF-α expression
were significantly increased in the basal acinar and stromal cells of MGs
in ApoE−/− mice compared to MGs of WT mice (Fig. 5C, D, E, and F).
Immunofluorescence staining and Western blot results showed up-reg-
ulation of both NF-κB p65 and p-NF-κB p65 in ApoE−/− mice (Fig. 5 G,
H and I). These results indicated that ApoE−/− mice have increased
levels of IL-6 and TNF-α, in part, through an enhancement of the NF-κB
pathway in MG.
3.4. Oxidative stress in MG of ApoE−/− mice
A significant increase of NOX-4 nuclear staining was observed in the
acinar epithelial cells of 5 and 7 month old ApoE−/− mice compared
with WT mice (Fig. 6A). We also observed a marked increase of 3-NT
and 4-HNE expression in MGs from ApoE−/− mice compared with WT
mice at 5 and 7 months (Fig. 6B and C). Western blot results confirmed
upregulated protein expression of NOX-4, 3-NT and 4-HNE in MGs of
ApoE−/− mice (Fig. 6D).
3.5. MG differentiation change in ApoE−/− mice
The terminal differentiation of sebocytes inside the MG acinus is
maintained by peroxisome proliferator-activated receptor-gamma
(PPAR-γ), which is a key factor for all lipid-synthesizing cells [34]. The
expression pattern of PPAR-γ gradually redistributes from the cyto-
plasm in infant and young adult mice to the nucleus in old mice [35].
Cytoplasm to nuclear translocation of PPAR-γ was also observed in
aged-related MGD [36].
Immunofluorescence staining showed nuclear and cytoplasmic
staining of PPAR-γ in meibocytes of WT mice, whereas in ApoE−/−
mice the staining pattern was exclusively observed only in the nucleus
(Fig. 6E). Western blot results showed that PPAR-γ was significantly
decreased in ApoE−/− mice compared to WT mice (Fig. 6F and G).
3.6. PPAR-γ agonist treatment prevent MG pathological change in ApoE−/
− mice
Rosiglitazone (ROSI) is a specific PPAR-γ agonist and GW9662 is a
specific PPAR-γ antagonist. To further determine the function of PPAR-
γ in MGs, 5 months old ApoE−/− mice (n = 30) were randomly divided
into a control (CON) group (PBS containing 0.01% DMSO, oral gavage,
one time daily, n = 10), a ROSI group (10 mg/kg, oral gavage, one time
daily, n = 10) and a GW9662 (3 mg/kg, oral gavage, 60 min before
Fig. 5. Inflammation in MG of ApoE−/−mice. Immunohistochemistry shows CD45 positive cell infiltration surrounding the acini of MGs (A), and a CD45 positive
cell density that is dramatically increased in the ApoE−/−mice (B). Immunofluorescence staining and mRNA levels of IL-6 (C, D) and TNF-α (E, F) disclose significant
upregulation in MGs of ApoE−/− mice compared to those of WT mice. Immunofluorescence of NF-κB p65 (G) and p-NF-κB p65 (H), and Western blot analysis (I) is
indicative of an activated NF-κB signaling pathway in MGs of ApoE−/− mice. Data are shown as mean ± SD. **p < 0.01, ***p < 0.001. Scale bars: 50 μm.
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ROSI, one time daily)+ROSI (10 mg/kg, oral gavage, one time daily)
group (n = 10). Two months later, the mice were examined by slit-
lamp microscopy before sacrifice. In the CON group, there was evidence
of pannus formation in the cornea (Fig. 7A), whereas in the ROSI group,
corneas remained transparent with a normal ocular surface throughout
the observation period. In GW9662 + ROSI group, on the other hand,
corneal pannus was also observed (Fig. 7A). Eyelids were excessively
keratinized and hypertrophic in CON and GW9662 + ROSI groups
(Fig. 7A), with no obvious abnormality in the ROSI group. Fluorescein
staining scores, moreover, were significantly decreased after 2 months
treatment with ROSI (Fig. 7B). Western blot analysis showed that
PPAR-γ was increased after administration of ROSI, while p-NF-κB p65
was suppressed (Fig. 7C). Immuno-staining for PPAR-γ showed that
ROSI increased the cytoplasmic expression of PPAR-γ in MG of ApoE−/
− mice (Fig. 7D). IL-6, TNF-α, K10, and p-NF-κB p65 immuno-staining
showed that ROSI application could decrease the expression of these
inflammation and keratinization related proteins in the MG of ApoE−/−
mice (Fig. 7D). CD45 staining also showed that ROSI could significantly
decrease the inflammatory cell infiltration of MGs in ApoE−/− mice
(Fig. 7E and F).
4. Discussion
Here, for the first time, we investigated the association between
hyperlipidemia and MGD using an ApoE−/− mouse model for hyperli-
pidemia, which has been widely used for research into atherosclerosis
and Alzheimer's disease. As previously reported [37], total cholesterol
concentration in serum was dramatically increased in ApoE−/− mice
compared with WT mice. Oil Red O staining showed accumulation of
condensed lipids in the MGs of 5 and 7 month old ApoE−/− mice, in-
dicating abnormal lipid metabolism in MGs.
We further characterized the clinical signs and pathological changes
of MG in ApoE−/− mice, which showed consistent and definitive
plugging of the MG orifice, in line with clinical observations supporting
the idea that the plugging of the MG orifice is a pathognomonic sign of
MGD [26,38]. Furthermore, ApoE−/− mice revealed cellular and
Fig. 6. Activation of oxidative stress and down-regulation of PPAR-γ in ApoE−/− mice. Immunohistochemical staining shows a relatively increased expression
of oxidative stress markers NOX-4 (A), 3-NT (B) and 4-HNE (C) in ApoE−/− mice, which was confirmed by Western blot analysis (D). Immunofluorescence staining
showed cytoplasmic and nuclear staining patterns of PPAR-γ in the MGs of WT mice, while only nuclear staining in the MGs of ApoE−/− mice (E). Western blot
analysis showing decreased PPAR-γ expression in ApoE−/− mice (F, G). Data are shown as mean ± SD. **p < 0.01. Scale bars: 50 μm.
J. Bu, et al. The Ocular Surface 17 (2019) 777–786
783
morphological changes of the glands that are consistent with the his-
topathology of MGD. Such changes included the presence of eyelid
hypertrophy, abnormal acini and dilated ducts [30,39–41]. We also
observed MG dropout in ApoE−/−mice, which is congruent with results
reported in patients with MGD [42]. K10 and FABP5 staining proved
hyper-keratinization of MG duct and acinar cells; Ki67 and P63 staining
supported decreased proliferation of acinar cells; TUNEL assay and AC-
caspase-8 staining suggested elevated apoptosis of MG.
We found heightened ocular surface epithelial cell damage and
corneal neovascularization in ApoE−/− mice at 5 and 7 months of age.
Since we did not find significant lipid deposition in the cornea of
ApoE−/− mice, the corneal neovascularization is not likely resulted
from lipid keratopathy, which was reported to be one of the patho-
genesis of corneal neovascularization [43]. Moreover, the ApoE gene
expression is much lower in corneal and conjunctival tissue compared
with that of MG (Figs. S1A and B), so the corneal pathological change
may not directly induced by ApoE knockout. We proposed two under-
lying mechanisms of corneal neovascularization in ApoE−/− mice.
Firstly, the inflammatory cytokines such as IL-6 and TNF-α were highly
expressed in the MG of ApoE−/− mice, and the concentrations of these
cytokines were also found increased in the aqueous tear of ApoE−/−
mice (Figs. S2A and B). Such cytokines could induce neovascularization
Fig. 7. PPAR-γ agonist treatment on ApoE−/− mice. Slit-lamp images indicating that ROSI treatment prevented pathological changes in the eyelid and cornea in
ApoE−/− mice, with eyelid margin hypertrophy (arrow heads) and corneal neovascularization (asterisk) evident in the untreated ApoE−/− mice and
GW9662 + ROSI treated ApoE−/−mice (A). The corneal fluorescein staining score decreased after ROSI treatment (B). Western blot analysis showing downregulated
p-NF-κB p65 and upregulated PPAR-γ expression in the ROSI treatment group (C). Immunofluorescent staining showing decreased IL-6, TNF-α and K10 expression in
the ROSI treatment group, along with an increased PPAR-γ expression (D). CD45 immunohistochemical staining showing decreased inflammatory cell infiltration in
the ROSI treated group (E), confirmed by cell counting (F). Data are shown as mean ± SD. **p < 0.01, ***p < 0.001. Scale bars: 50 μm. ROSI, Rosiglitazone;
CON, control group; G+R, GW9662 + ROSI group; R, ROSI group.
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in a long run of 5–7 months. Secondly, there was hyper-keratinization
and thickening of the eyelid margin in ApoE−/− mice of 5–7 months
old. Such eyelid margin changes may cause damage of the cornea
during eyelid blinking and then result in neovascularization, which was
reported in other eyelid margin related diseases [44,45].
Hyperkeratinization is a major reason for obstructive MGD and
causes degenerative gland dilatation and atrophy [39]. Abnormal MG
lipid is one of the factors that could induce epithelial keratinization and
MG obstruction [35,46]. H&E staining showed dilation of MG ducts,
while gene expression and immunofluorescence analyses demonstrated
upregulated K10 and FABP5 expression in MG ducts and acinar cells of
ApoE−/− mice. These results indicated that the MGs of 7-month-old
ApoE−/− mice underwent hyperkeratosis which could lead to ob-
structive MGD, and progressive lipid accumulation in acini and ducts
that likely triggers a vicious cycle of pathological change.
Inflammatory cell infiltration in the surrounding microenvironment
of MGs in ApoE−/− mice may be attributed to hyperlipidemia and/or
MGD. Hyperlipidemia can induce metabolic inflammation and the
production of cytokines to damage vascular smooth muscle cells [47].
Hyperlipidemia can also induce infiltration of foamy macrophages in
aortic adventitial, eventually leading to aortic dilation [48]. Reyes and
associates have pointed to the important role for polymorphonuclear
neutrophils in the pathogenesis and progression of MGD [49]. We found
inflammatory cell infiltration of the eyelid by CD45 staining sur-
rounding the microenvironment of the MGs, along with increased ex-
pression of inflammatory cytokines such as IL-6 and TNF-α in acinar
cells. These changes mimic the histopathological, functional and in-
flammatory changes of MGD. NF-κB plays an important role in reg-
ulating innate immune and inflammatory responses [50,51]. Therefore,
we investigated whether this finding is associated with an up-regulation
of the NF-κB signaling pathway. The finding in the ApoE−/− mice that
the NF-κB signaling pathway was activated in the MG of ApoE−/− mice
further confirms the inflammatory environment of the MG.
Lipid oxidation may be another pathogenic mechanism inducing
MG inflammation in ApoE−/− mice. Exaggerated lipid accumulation in
acinar cells could, we hypothesized, have induced reactive oxygen
species; this was confirmed by the expression of oxidation related
markers in MGs. Oxidation is a well-known mechanism that promote
inflammation in different tissues, and activates the expression of in-
flammatory cytokines [52,53]. PPAR-γ is the major signal controlling
element for lipid synthesis and sebaceous gland function [54–56].
Oxidative stress can also modulate PPAR-γ expression [57]. We de-
tected the down-regulation of PPAR-γ, along with an alteration in cy-
toplasmic and nuclear expression patterns of PPAR-γ to a solely nuclear
pattern in MG of ApoE−/− mice. This is similar to age-related MGD
[35]. Indeed, PPAR-γ dependent signaling is already known to play a
role in inflammation control [58]. Therefore, down-regulation of PPAR-
γ may be related to the inflammatory condition of the MGs in ApoE−/−
mice. We then tested rosiglitazone, a PPAR-γ agonist, on the in-
flammation and keratinization of MGs in ApoE−/−mice, and found that
the treatment significantly restored the expression pattern of PPAR-γ,
consistent with previous reports [59]. Treatment also reduced expres-
sion of inflammatory cytokines IL-6 and TNF-α, downregulated NF-κB
signaling pathway, reduced keratinization of MGs, and lowered in-
flammatory cell infiltration. Rosiglitazone also has potential anti-in-
flammatory effects on the ocular surface [60]. As a result, the effect of
rosiglitazone on the MGs and ocular surface together prevented the
ocular surface changes of ApoE−/− mice and resulted in a relatively
healthy ocular surface being maintained. We therefore consider the
PPAR-γ agonist to have a therapeutic effect on hyperlipidemia related
MGD.
Based on our results, the inflammation of the MG acinar cells and
the inflammation of surrounding microenvironment may both con-
tribute to the pathogenesis of MGD in ApoE−/− mice. Which one plays
the major role, or which one is the primary pathological process, or
these two processes form a vicious cycle need further investigation. In
summary, ApoE−/− mice showed MG obstruction with MG dropout,
excessive keratinization, abnormal MG acinar cell proliferation, dif-
ferentiation, lipid metabolism and an increased inflammatory cell in-
filtration in the MG, thus leading to obstructive MGD and ocular surface
changes. ApoE−/− mice may be used as a model to study the patho-
physiology of MGD and may help us to understand the relationship
between lipid metabolism related disorders and MGD.
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